What Every Clinician Needs to Know About COVID-19 and Thrombosis
| Overview / Abstract: |
As the COVID-19 pandemic continues to wage on, are you prepared to prevent and treat your patients for COVID-19-related venous thromboembolism (VTE)? In this short vlog, learn how to develop appropriate regimens with antithrombotic therapy for this patient population and hear about the promising PREVENT-HD trial. Leading VTE expert, Dr. Gregory Piazza, outlines key real-world insights that you need to know about these patients and their risk for VTE. |
|
Expiration |
Sep 30, 2022 |
|
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME |
|
Format |
Online, Webinar / Webcast / Video |
|
Credits / Hours |
.25 AMA PRA Category 1 Credit(s)™ |
|
Accreditation |
ACCME |
|
Presenters / Authors / Faculty |
Gregory Piazza, MD, MS |
|
Activity Specialities / Related Topics |
Cardiology / Cardiovascular, Primary Care |
|
Sponsors / Supporters / Grant Providers |
This activity is supported by an educational grant from Janssen Scientific Affairs, LLC. |
|
Keywords / Search Terms |
ACHL CME, CME/CE, Janssen, Gregory Piazza, Piazza, anticoagulant, thrombosis, covid-19, vlog, thromboprophylactic, heparin, low-dose, ISTH, half-dose, prophylactic, hemostasis, Endothelial, inflammation, cell death, apoptosis, Coagulation, Antithrombotic, prophylaxis, LMWH, ACCP, ASH, guidelines, critically ill, hospitalized, intensity, regimen, VTE, PREVENT-HD, screening, outpatient, risk factor, PCR, antigen, COPD Free CE CME |
|